Johns Hopkins: ultrasensitive PSA after surgery predicts biochemical relapse

We’ve looked at several retrospective studies this year that found that early ultrasensitive PSA (uPSA) results following surgery can reliably predict eventual biochemical relapse. Johns Hopkins examined its own database and found the same thing. … READ MORE …

Can ultrasensitive PSA at 3 years post-surgery project delayed BCR?

A research team at New York University School of Medicine has reported data suggesting that a single ultrasensitive PSA test result may be able to project risk for delayed biochemical recurrence (BCR) of prostate cancer at 3 years after a radical prostatectomy. … READ MORE …

Prostate cancer news reports: Sunday, November 8, 2009

This weekend’s news report includes items on:

  • Numbers of biopsy cores and accuracy of diagnosis for focal therapy
  • Early data from the Prostate Cancer Research International: Active Surveillance (PRIAS) study
  • Ultrasensitive PSA testing and risk of progression following radical prostatectomy … READ MORE …